Should the cardio‐protective properties of sodium‐glucose cotransporter 2 inhibitors dictate therapeutic decision‐making in patients with type 2 diabetes

2020 ◽  
Vol 50 (5) ◽  
pp. 645-646
Author(s):  
Tamara Y. Milder ◽  
Richard O. Day ◽  
Sophie L. Stocker ◽  
Jerry R. Greenfield
Keyword(s):  
Type 2 Diabetes ◽  
Decision Making ◽  
Therapeutic Decision ◽  
Protective Properties ◽  
Sodium Glucose Cotransporter ◽  
Therapeutic Decision Making

scholarly journals Beta-cell Insufficiency

2017 ◽  
Vol 13 (02) ◽  
pp. 51 ◽  
Author(s):  
Sanjay Kalra ◽  
Yashdeep Gupta ◽  
◽  
Keyword(s):  
Type 2 Diabetes ◽  
Decision Making ◽  
Beta Cell ◽  
Taxonomic Structure ◽  
Therapeutic Decision ◽  
Anatomy And Physiology ◽  
Beta Cell Failure ◽  
Three Phase ◽  
Therapeutic Decision Making

‘B eta-cell failure’ is a frequently used term to describe the structural and functional inability of the cells to fulfil their metabolic responsibility. This editorial reviews the anatomy and physiology of the beta cell, and describes factors which regulate this. The authors focus on semantics, comparing the phrases ‘beta-cell failure’, ‘functional mass’, and ‘beta-cell insufficiency’. They suggest the use of ‘beta-cell insufficiency’, with descriptors such as ‘partial’ and ‘complete’, or ‘reversible’ and ‘irreversible’, to convey betacell dysfunction in type 2 diabetes. A three-phase taxonomic structure: beta-cell sufficiency, partial/reversible beta-cell insufficiency and complete/irreversible beta-cell insufficiency, is proposed as a tool to understand pathophysiology and facilitate therapeutic decision-making.

Somatic Mosaicism in a Patient with Gaucher Disease Type 2: Implication for Genetic Counseling and Therapeutic Decision-Making

2000 ◽  
Vol 26 (6) ◽  
pp. 611-612 ◽  
Author(s):  
Mirella Filocamo ◽  
Gloria Bonuccelli ◽  
Raffaella Mazzotti ◽  
Fabio Corsolini ◽  
Marina Stroppiano ◽  
...  
Keyword(s):  
Decision Making ◽  
Genetic Counseling ◽  
Gaucher Disease ◽  
Somatic Mosaicism ◽  
Disease Type ◽  
Therapeutic Decision ◽  
Therapeutic Decision Making

Genotyping might help therapeutic decision-making in patients with von Willebrand disease type 2 B

Haemophilia ◽  
2016 ◽  
Vol 22 (5) ◽  
pp. e439-e443 ◽  
Author(s):  
L. Rugeri ◽  
M. Fretigny ◽  
Y. Dargaud ◽  
C. Nougier ◽  
C. Vinciguerra
Keyword(s):  
Decision Making ◽  
Disease Type ◽  
Von Willebrand Disease ◽  
Therapeutic Decision ◽  
Therapeutic Decision Making ◽  
Von Willebrand

1552-P: Machine Learning Approach to Decision-Making for Initial Insulin Use in Japanese Patients with Type 2 Diabetes

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1552-P
Author(s):  
KAZUYA FUJIHARA ◽  
MAYUKO H. YAMADA ◽  
YASUHIRO MATSUBAYASHI ◽  
MASAHIKO YAMAMOTO ◽  
TOSHIHIRO IIZUKA ◽  
...  
Keyword(s):  
Machine Learning ◽  
Type 2 Diabetes ◽  
Decision Making ◽  
Japanese Patients ◽  
Learning Approach ◽  
Machine Learning Approach ◽  
Insulin Use
Sign in / Sign up

Export Citation Format

Share Document